Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma

NCT04003168 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Human BCMA targeted T Cells Injection

Sponsor

Hrain Biotechnology Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]